| Health / Medical Topics |
Biguanide Antidiabetic Agent
Any antidiabetic agent with the biguanide base structure or phenformin derivatives with antihyperglycemic activity. Biguanide antidiabetic agents activate AMP-activated protein kinase (AMPK) resulting in decreased glucose production in the liver, increased peripheral glucose uptake and improved utilization of glucose. Biguanide-based antidiabetic agents do not cause hypoglycemia. In addition, biguanide antidiabetics decrease absorption of glucose from the gastrointestinal tract. (NCI Thesaurus)
YOU MAY ALSO LIKE
Biglycan (368 aa, ~42 kDa) is encoded by the human BGN gene. This protein plays a role in connective tissue structure. …
Premature heartbeats alternating regularly with normal beats. It can be associated with hypoxia, ischemia, acute myocardial infarction, and medication overdose.
A theoretical measure of the execution of an algorithm, usually the time or memory needed, given the problem size n, which is…
A division of a main body into two parts.
Bifunctional purine biosynthesis protein PURH (592 aa, ~65 kDa) is encoded by the human ATIC gene. This protein plays a role in…
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial (350 aa, ~38 kDa) is encoded by the human MTHFD2 gene. This protein is involved in folate…
